Journals / Bozok Tıp Dergisi / 2026 / Cilt: 3 Sayı: 2

Primary Central Nervous System Lymphoma: Report of Three Cases

PRİMER SANTRAL SİNİR SİSTEMİ LENFOMASI: ÜÇ OLGU SUNUMU

Pages
70–74
Publication Date
2013-06-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The clinical radiographic, pathologic features and prognosis of these rare cases are discussed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Primary central nervous system (PCNS) lymphoma is defined as the lymphoma effecting only spinal axis and cranium without systemic symptoms.
📊
Key Findings & Data:PCNS Non-Hodgkin’s lymphoma is representing 5 % of all primary brain tumors and occurring more frequently in the last years.
💡
Conclusion & Impact:The clinical radiographic, pathologic features and prognosis of these rare cases are discussed.
🔬Design:Makale
📍Scope:Comprehensive Sample
⚙️Variables:Santral sinir sistemi hastalıkları · Lenfoma · Non-Hodgkin

Abstract

Primary central nervous system (PCNS) lymphoma is defined as the lymphoma effecting only spinal axis and cranium without systemic symptoms. PCNS Non-Hodgkin’s lymphoma is representing 5 % of all primary brain tumors and occurring more frequently in the last years. It occurs frequently in patients with sporadic or acquired immunodeficiency syndromes, which traditionally have been treated with radiotherapy. For nonimmunosupression patients, whole brain Gray irradiation (30 to 40 Gy) with a 10– 20 Gy local boost to the primary tumor is suggested. Whole-brain radiation therapy with a median survival of 12-18 months was regarded standard chemotherapy introduced combined modality treatment increasing median survival to 37-60 months. The clinical radiographic, pathologic features and prognosis of these rare cases are discussed.

Özet

Primer santral sinir sistemi lenfoması (PSSSL), santral sinir sisteminde ortaya çıkan eks- tra nodal bir non-Hodgkin lenfoma (NHL) türüdür. Son yıllarda görülme sıklığı giderek artmaktadır. Tüm beyin tümörlerinin yaklaşık %5’ini, lenfomaların %1’ini oluşturmakta- dır. Tipik olarak yaşlı hastalığı olup, erkeklerde insidansı fazladır. PSSSL’ında radyoterapi (RT) sık uygulanmakta olup, tüm beyin ışınlaması (30–40 Gy) ve primer tümöre yönelik (10–20 Gy) lokal boost uygulaması, klinik ve radyolojik cevap oranını artırmaktadır. Sade- ce cerrahi uygulanan olgularda rekürrens riski daha yüksek olup, cerrahiye radyoterapi eklenen olgularda sağ kalım 12–18 ay iken kemoterapi ile birlikte kombine tedavi metod- ların uygulanması sağ kalım 37-60 aya kadar uzamaktadır. Bu yazıda kliniğimizde tedavi ettiğimiz üç olgu literatür eşliğinde tartışılarak sunuldu.

🔖

Cite This Article

Cihan, Y. B. (2013). Primary Central Nervous System Lymphoma: Report of Three Cases. Bozok Tıp Dergisi, Cilt: 3 Sayı: 2, 70–74. https://ajindex.com/articles/1378066

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...